Spots Global Cancer Trial Database for fenretinide
Every month we try and update this database with for fenretinide cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Trial of Intravenous Fenretinide Emulsion for Patients With Relapsed/Refractory Peripheral T-cell Lymphomas | NCT02495415 | Peripheral T-ce... | Fenretinide | 18 Years - | CerRx, Inc. | |
| Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome | NCT00003601 | Melanoma (Skin) | fenretinide tretinoin | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer | NCT00001378 | Breast Cancer Breast Neoplasm... | fenretinide | - | National Institutes of Health Clinical Center (CC) | |
| Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer | NCT00002646 | Breast Cancer | fenretinide tamoxifen citra... | - | National Cancer Institute (NCI) | |
| Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk | NCT00017134 | Ovarian Cancer | fenretinide conventional su... | 18 Years - | GOG Foundation | |
| Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | NCT00387504 | Unspecified Adu... | fenretinide pharmacological... | 18 Years - | California Cancer Consortium | |
| 4-HPR and FTI in Head and Neck Squamous Cell Carcinoma (HNSCC) | NCT00102635 | Head and Neck C... | Fenretinide (4-... SCH66336 | - | M.D. Anderson Cancer Center | |
| Combination Chemotherapy in Treating Patients With Solid Tumors | NCT00009932 | Unspecified Adu... | cisplatin fenretinide paclitaxel | 18 Years - | National Cancer Institute (NCI) | |
| Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | NCT00387504 | Unspecified Adu... | fenretinide pharmacological... | 18 Years - | California Cancer Consortium | |
| Fenretinide in Treating Patients With Recurrent Malignant Glioma | NCT00006080 | Brain and Centr... | fenretinide | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Fenretinide in Treating Children With Recurrent or Resistant Neuroblastoma | NCT00053326 | Recurrent Neuro... | fenretinide pharmacological... | - 21 Years | National Cancer Institute (NCI) | |
| Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer | NCT00002646 | Breast Cancer | fenretinide tamoxifen citra... | - | National Cancer Institute (NCI) | |
| Chemotherapy in Treating Patients With Advanced Kidney Cancer | NCT00011973 | Kidney Cancer | fenretinide | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate Cancer | NCT00080899 | Adenocarcinoma ... Recurrent Prost... | fenretinide laboratory biom... | - | National Cancer Institute (NCI) | |
| Fenretinide in Healthy Young Women at Genetic and Familial Risk | NCT01479192 | High-Risk Cance... | Fenretinide Placebo | 20 Years - 46 Years | European Institute of Oncology | |
| Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer | NCT00009971 | Lung Cancer | fenretinide | 18 Years - | National Cancer Institute (NCI) | |
| Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma Multiforme | NCT00075491 | Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Recurrent Adult... | fenretinide therapeutic con... pharmacological... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth | NCT00003223 | Head and Neck C... | fenretinide | 18 Years - | SWOG Cancer Research Network | |
| Fenretinide in Treating Patients With Recurrent Malignant Glioma | NCT00006080 | Brain and Centr... | fenretinide | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Fenretinide in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer | NCT00026091 | Recurrent Ovari... Recurrent Prima... Stage IV Ovaria... Stage IV Primar... | fenretinide laboratory biom... pharmacological... | - | National Cancer Institute (NCI) | |
| N2004-03: Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant Neuroblastoma | NCT00646230 | Neuroblastoma | fenretinide high performanc... pharmacological... | 0 Years - 30 Years | Children's Hospital Los Angeles | |
| Fenretinide in Treating Patients With Cervical Neoplasia | NCT00003075 | Cervical Cancer Precancerous Co... | Fenretinide Placebo | 18 Years - | M.D. Anderson Cancer Center | |
| Fenretinide in Treating Patients With Cervical Neoplasia | NCT00003075 | Cervical Cancer Precancerous Co... | Fenretinide Placebo | 18 Years - | M.D. Anderson Cancer Center | |
| Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome | NCT00003601 | Melanoma (Skin) | fenretinide tretinoin | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the Ovaries | NCT00098800 | brca1 Mutation ... brca2 Mutation ... Ovarian Cancer | fenretinide | 30 Years - | University of Arizona | |
| Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | NCT00387504 | Unspecified Adu... | fenretinide pharmacological... | 18 Years - | California Cancer Consortium | |
| Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome | NCT00003601 | Melanoma (Skin) | fenretinide tretinoin | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk | NCT00017134 | Ovarian Cancer | fenretinide conventional su... | 18 Years - | GOG Foundation | |
| Fenretinide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | NCT00006471 | Head and Neck C... | Fenretinide | 18 Years - | M.D. Anderson Cancer Center | |
| Fenretinide in Treating Children With Solid Tumors | NCT00003191 | Neuroblastoma Unspecified Chi... | fenretinide | - 21 Years | National Cancer Institute (NCI) | |
| Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer | NCT00004154 | Bladder Cancer | Fenretinide Placebo | 18 Years - | M.D. Anderson Cancer Center | |
| Fenretinide in Treating Patients With Leukoplakia of the Mouth | NCT00004161 | Head and Neck C... | fenretinide Placebo | 18 Years - | University of Alabama at Birmingham | |
| Chemoprevention Therapy Plus Surgery in Treating Women With Breast Cancer | NCT00003099 | Breast Cancer | Fenretinide Tamoxifen Citra... Placebo | 18 Years - | M.D. Anderson Cancer Center | |
| Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer | NCT00077402 | Prostate Cancer | fenretinide | 18 Years - | National Cancer Institute (NCI) | |
| N2004-03: Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant Neuroblastoma | NCT00646230 | Neuroblastoma | fenretinide high performanc... pharmacological... | 0 Years - 30 Years | Children's Hospital Los Angeles | |
| Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | NCT00005819 | Unspecified Adu... | cisplatin fenretinide paclitaxel | 18 Years - | Case Comprehensive Cancer Center | |
| Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer | NCT00002646 | Breast Cancer | fenretinide tamoxifen citra... | - | National Cancer Institute (NCI) | |
| Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma | NCT00288067 | Adult Nodular L... B-cell Chronic ... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Stage II Margin... Stage II Small ... Extranodal Marg... Nodal Marginal ... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Grade... Recurrent Grade... Recurrent Mantl... Recurrent Margi... Recurrent Small... Refractory Chro... Splenic Margina... Stage I Adult B... Stage I Adult D... Stage I Adult H... Stage I Adult L... Stage I Chronic... Stage I Grade 1... Stage I Grade 2... Stage I Small L... Stage II Adult ... Stage II Chroni... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Chron... Stage III Grade... Stage III Grade... Stage III Mantl... Stage III Margi... Stage III Small... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Chroni... Stage IV Grade ... Stage IV Grade ... Stage IV Mantle... Stage IV Margin... Stage IV Small ... Waldenström Mac... | fenretinide rituximab | 18 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
